Improve Aspects of Bioproduct Development by Leveraging Cutting-Edge Technical and Process Innovation
May 18-20, 2015 | Parc 55 Hilton | San Francisco, CA
Alternative Language Options:
We Want Your Opinion! Help us better understand where the biggest opportunities are to advance cancer therapeutics. »Please share your insights
Updated: March 26, 2015
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products.
Catalent is your strategic partner for biologic drug development success. We create smart, tailored solutions with our novel SMARTag™ ADC Technology, our market leading GPEx® cell line expression system , expanded biomanufacturing capabilities and integrated development and analytical services to help you get more products and better treatments to clinic faster.
At Molecular Devices, we enable our customers to unravel the complexity of biological systems by providing platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection.
Novozymes Biopharma is dedicated to providing biological-based ingredients and technologies, such as recombinant albumin, hyaluronic acid and enzymes for the pharmaceutical and medical device industries. We help customers overcome challenges throughout their development process – all the way from greener biocatalytic processes for optimized manufacturing, to improved drug stabilization and half-life extension for therapeutics formulations.
Young Investigator Poster Award Sponsor
Copyright IBC Life Sciences, a part of Informa Life Sciences Group.Phone: 800.390.4078Email: email@example.com